Revisiting the Role of Genetic Testing in Patients at Risk for Late-Onset Alzheimer’s Disease: How Will the Latest Evidence and Evolving Management Paradigm Impact Treatment Decisions for Your Patients?
•Als PPT, PDF herunterladen•
0 gefällt mir•9 views
Chair, Robert C. Green, MD, MPH, Liana G. Apostolova, MS, MD, FAAN, and Stephen P. Salloway, MD, MS, discuss Alzheimer’s disease in this CME/NCPD/CPE/ASWB-ACE/IPCE activity titled “Revisiting the Role of Genetic Testing in Patients at Risk for Late-Onset Alzheimer’s Disease: How Will the Latest Evidence and Evolving Management Paradigm Impact Treatment Decisions for Your Patients?” For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/ASWB-ACE/IPCE information, and to apply for credit, please visit us at https://bit.ly/3ZwBKIA. CME/NCPD/CPE/ASWB-ACE/IPCE credit will be available until April 15, 2024.
